WARF Triumphs in Latest Chapter of hESC Patent Challenge
A California-based effort to ease patent restrictions on the research use of human embryonic stem cells last week suffered a severe blow when a federal court of appeals ruled in favor of a Wisconsin organization known as WARF.
At the heart of the matter is the question of who profits from stem cell research along with whether the patents stifle scientifi…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.